Long Ideas - AVEO Pharmaceuticals (NASDAQ:AVEO) announced on Thursday morning that the company will be presenting new data for both of its lead candidates, tivozanib and ficlatuzumab, at … Continue Reading
Read nowQuick Picks - Delcath Systems (NASDAQ:DCTH) is trading with above-average volume for the second day in a row, but after gapping up 8% at the open, is giving … Continue Reading
Read nowLong Ideas - After a Buy rating from theStreet.com yesterday and a presentation Wednesday morning at the UBS Global Life Sciences conference, NPS Pharmaceuticals (NASDAQ:NPSP) gapped up 4% … Continue Reading
Read nowQuick Picks - Spectrum Pharmaceuticals (NASDAQ:SPPI) moves another cancer treatment further along the pipeline on Wednesday with the initiation of a Phase III trial of Zevalin as a … Continue Reading
Read nowLong Ideas - On Tuesday morning, Navidea Biopharmaceuticals (NASDAQ:NAVB) announced that it commenced enrollment of a Phase II trial for its radiopharmaceutical agent, NAV4694, which is being tested … Continue Reading
Read nowQuick Picks - Shares of Optimer Pharmaceuticals (NASDAQ:OPTR) are off 6% from their peak earlier this month, and have fallen nearly 15% from their 52-week high, as investors … Continue Reading
Read nowMost Popular - Investors received word Monday morning of a positive ruling on Jazz Pharmaceuticals’ (NASDAQ:JAZZ) Xyrem patent case with Roxane Laboratories, a subsidiary of Boehringer Ingelheim. In 2010, … Continue Reading
Read now